Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
National Cancer Institute Renews Georgetown Lombardi Top Designation
Explore this page to find the official news release about this achievement as well as supporting information about the cancer center and its work.
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
Designation as Comprehensive Cancer Center Consortium Includes John Theurer Cancer Center
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University’s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Follow This News on Social Media (#WeAreNCIDesignated)
An NCI Designation: What Does It Mean For Patients?
Jaime Posada was diagnosed with stage 4 lung cancer and given two to six months to live. That was in 2017, before he came to Georgetown Lombardi.
John L. Marshall, MD, chief medical officer of Georgetown Lombardi, explains what being treated at a “Comprehensive Cancer Center” means from a patient’s perspective.
“This highly coveted cancer center support grant requires considerable virtuosity in laboratory and translational research, clinical research, population science research, community outreach and engagement, and in training the next generation of cancer researchers and clinicians.”
Georgetown Lombardi by the Numbers
(Note: Timeframe of cited statistics is 2019-2024)
2Campus Locationsin DC and New Jersey
6.5 MillionPeoplein Our DC & New Jersey Service Areas
$35M+Per YearCancer Research Funding
3Research ProgramsInvestigating the Cancer Continuum From Genes to Populations
114Research Faculty Members54 New in Past Five Years
28%of 1,000+ Research PublicationsPublished in High-Impact Journals
$2.2Min Training Award Funding3 T32 Training Grants
110Treatment Studies Available to Patients
500+PatientsEnrolled in Treatment Studies Annually
Who We Serve
Georgetown Lombardi, together with our academic health system partner, MedStar Health, and our consortium research partner, John Theurer Cancer Center, serves 6.5 million people living in the District of Columbia and neighboring counties in Maryland and Virginia, as well as northern New Jersey.
How We Serve
Georgetown Lombardi is able to provide the quality of care to those it serves thanks to robust clinical partnerships with our academic health system partner, MedStar Health, including clinical affiliate sites MedStar Georgetown University Hospital and MedStar Washington Hospital Center, and with our research consortium partner, John Theurer Cancer Center, and its network of clinics and hospitals in New Jersey.
Georgetown Lombardi’s Impact
Translational Research
Clinical Cancer Research
Laboratory Research
Community Outreach
Diversity, Equity & Inclusion
Reducing Health Disparities
